cdmo.directory
← Compare landing

eXmoor Pharma vs Hillgene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/exmoorpharma/hillgene

CategoryeXmoor PharmaHillgene
Listed sitecdmocdmo
SummaryIntegrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • Process Development
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • mRNA Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • mRNA
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
  • Immunology
Locations
  • Headquarters
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
CertificationsData not yet provided.
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.